Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-29

Clinical Trial Update: Desloratadine in Patients With Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial studying desloratadine in patients with ulcerative colitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desloratadine (desloratadine)

Snippet

Sponsor: Tanta University | Conditions: Ulcerative Colitis (UC), Ulcerative Colitis | Phase 2 | Status: RECRUITING